chrisvoncsefalvay/vaers-outcomes huggingface dataset:
runny nose; sore throat; trouble breathing; headaches; This is a spontaneous report from a contactable consumer (Patient). A 70-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on 23Mar2021 (Batch/Lot number was not reported) AND dose 1 via an unspecified route of administration on 03Mar2021 (Batch/Lot number was not reported) both as single dose for covid-19 immunisation. Medical history included ongoing COPD. The patient's concomitant medications were not reported. On an unspecified date, the patient experienced runny nose, sore throat, trouble breathing and headaches. Therapeutic measures were taken as a result of adverse event. Patient received the first dose of the Pfizer COVID-19 vaccine on 03March2021 and the second dose on 23Mar2021 and had recently developed a runny nose, sore throat, trouble breathing and headaches, she does have COPD and was under a doctors care. Stated her doctor/Nurse PR actioner had given her medication and inhalers and would like her to go to the emergency room because of her breathing but she does not want to do that, she was wondering if she can get test of the COVID-19 virus. The outcome of event was unknown.   The lot number for the vaccine, [BNT162B2] was not provided and will be requested during follow-up.
This spontaneous medically confirmed report (initial receipt 16-Jan-2015) concerns a 57-year-old female patient. On an unspecified date, the patient received an influenza virus vaccine (manufacturer and batch number not provided). On an unspecified date, the patient experienced 'a life threatening reaction' possibly within the last one or two years. The outcome was unknown. Reporter's comments: It was not known if the influenza vaccine was AFLURIA.
Started losing vision in both eyes after second shot on March 31, 2021.  They are doing steroid injections, temporial artery biopsy and lots of blood test.  Vision is still basically gone and tingling and no strength at all.
After 1 dost dose of Pfizer was given to the left arm of the patient,  Pt was instructed to have a seat for 15 minutes. Pt started to shop after and came back to the pharmacy and reported symptoms of flush face, rash, dizziness, upset stomach and throat tightness of throat and slight SOB.  Monitored the patient for symptoms after 5 minutes, the patient said she felt slightly better.  After another 5 minutes the pt said her throat felt tight again and dizzy again as well. I administered the Epi-pen 0.3 mg in the upper left thigh at 7:35 pm  and called EMS from hospital.  After checking again in 5 minutes the patient states she felt better and most symptoms resolved including tightness of throat and SOB. I did not administer another dose.  The EMS arrived checked vitals and reported her BP was normal and cleared the patient to check with MD office for followup. I agreed with the EMS and obtained pt contact info for followup and advised likewise.
This spontaneous report as received from a registered nurse refers to a 6 year old patient. The nurse reported the patient received PROQUAD (Merck) (dose and lot # not reported) and VARIVAX (Merck) (dose and lot # not reported) on 31-JUL-2013. No adverse symptoms were reported. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information is not expected.
IPV and MMR given in left arm on 10/14/2005 following day patient had fever of 1020, arm became red and swollen from mid clavicle to just above antecubital fossa. Seen in ER and then admitted to hospital given IV Unasyn and IV Benadryl. Sent home on Augmentin and PO Benadryl. Medical records state anorexia, pain.
immunocompromised patient received booster dose instead of full 3rd dose; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (immunocompromised patient received booster dose instead of full 3rd dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.   In November 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In November 2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (immunocompromised patient received booster dose instead of full 3rd dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (immunocompromised patient received booster dose instead of full 3rd dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were provided.  No treatment medication were provided.  The patient was on active chemotherapy.
Local redness, swelling, warmth, increased circumference of arm left side redness extends 19cm in length.
Developed focal seizure lasting > 35 minutes on 4/17/04. Received 2 doses of Ativan in ER; CT head negative.  Nurse follow up on 06/18/04 states: "ADD: Fever, gait abn, eye deviated, leg/arm shaking, rash."
Pt std onset began 8/6/2021 with extreme fatigue and SOB. All other symps gradually developed. Pt was admitted into the hospital 8/9-8/11. Pt has also been fully vaccinated. Pt has a med hx of Heart disease and 2 hip replacements.  Symptoms: fever, chills, muscle or body aches, new loss of taste or smell, runny nose/congestion, sore throat, cough, shortness of breath, chest pain, fatigue, headache, diarrhea.
I took the Pfizer vaccine on July 10, 2021.  I had COVID in April, so I still had the antibodies as I was tested beforehand. I was extremely sick for about 7 days after taking the vaccine, with a fever and body aches. About a week after the vaccine, I started experiencing pain particularly in my right foot, that become so sever I could barely walk.  It spread throughout my body to my knees and legs and my arms. I  was also experiencing tingling in my hands and feet that was  overwhelming and causes me to have to stop my daily activities. I still experience hot finger tips and my brain fog has worsened practically when eating, which causes me not to be able to eat at times. It has been about 5 weeks since the shot and I am still not 100% feeling better. Right now I'm mainly  experiencing a slight burning and tingling sensation in my back which makes me feel over heated and I'm sweating all the time. I'm also extremely dehydrated and feel like I'm going to pass out even when I'm drinking a lot of water.  I am not sure if I should get the second shot, and would appreciate any feedback on why I'm experiencing this. Hopefully I can hear from someone soon as my decision to get the second shot is time sensitive as my university is requiring it.
Patient had been previously diagnosed with Asthma in January 2008 after returning home from a 15-month deployment where asthma symptoms began. After about one month of treatment, all symptoms ceased and patient ceased to take any medication. Symptoms had been nonrecurrent since February 2008. Within 24 hours of Flumist administration, asthma symptoms returned in full force. Patient says symptoms are identical to the ones he had when they began in 2007.
ADMINISTRATION OF JANSSEN COVID 19 VACCINE AFTER RECEIVING AND HAVING AN ALLERGIC REACTION TO THE PFIZER COVID VACCINE; This spontaneous report received from a patient concerned a 74 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: allergic reaction to the pfizer covid vaccine. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 207A21A, expiry: 21-SEP-2021) dose was not reported, administered on 14-MAY-2021 for prophylactic vaccination. Concomitant medications included bnt 162 for prophylactic vaccination. On 14-MAY-2021, the patient experienced administration of janssen covid 19 vaccine after receiving and having an allergic reaction to the pfizer covid vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of administration of janssen covid 19 vaccine after receiving and having an allergic reaction to the pfizer covid vaccine was not reported. This report was non-serious.
TRANSPARENT URINE; MILD HEADACHE; This spontaneous report received from a patient concerned a 47 year old female. The patient's weight was 54 kilograms, and height was 60 inches. No past medical history or concurrent conditions were reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A, expiry: UNKNOWN) dose was not reported, administered on 22-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 22-MAY-2021, the subject experienced transparent urine. On 22-MAY-2021, the subject experienced mild headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from transparent urine, and the outcome of mild headache was not reported. This report was non-serious. This case, from the same reporter is linked to 20210545645.
Interestingly, I had only a minimally sore arm after my fist Moderna shot.  I received my second Moderna shot on April 14, 2021. Side effects began at 2:00 a.m. on April 15, 2021 and continued throughout most of the day. The included the following: Minimally sore arm Moderate headache unaffected by Tylenol for Arthritis or aspirin.  Nausea.  Unable to force an food down for breakfast or lunch. I have diabetes and take four insulin shots a day, so being unable to eat is a problem Blood sugars ran between 200 and 300 despite my taking a few units  of insulin on an empty stomach. Weak and shaky Temperature ranged between 98.0 and 100.5.  My normal  temperature is less than 98.0  I was able to eat between one-half and one cup of Campbell's chicken  noodle soup for supper with a few crackers and awoke on April 16 a new woman.
Patient vaccinated and informed to wait 15 minutes post vaccine prior to departing. Patient left approx. 10 minutes after vaccine was administered and walked to her vehicle. Upon arriving at vehicle, became lightheaded, had itchy arms, had a scratchy throat. Walked back to vaccination clinic and an outpatient response team was called, patient transported to ED.
This spontaneous report as received from a medical assistant refers to a male patient of unknown age. On 01-AUG-2014 the patient was vaccinated with a dose of GARDASIL, (0.5 ml, intramuscular) and inadvertently, he was administered another dose of GARDASIL on 05-AUG-2014. Pertinent medical history and concomitant medications were unspecified by the reporter. No adverse effects reported. The outcome of the events was unknown. No further information provided. Additional information has been requested.
Information has been received through the Merck pregnancy registry for GARDASIL through a nurse concerning a 23 year old female with an allergy to FLAGYL who in August 2007, was vaccinated with her first dose of GARDASIL.  There was no concomitant medication.  The reporter stated that the patient received her first dose of GARDASIL while pregnant in another office (LMP = 11-JUL-2007).  It was reported that the patient had an ultrasound (no additional information provided).  The patient sought unspecified medical attention by seeing the physician.  Follow-up phone call information from a nurse reported that the patient had a intrauterine fetal demise (IUFD) at 25 weeks gestation on 08-JAN-2008.  There were placental abnormalities and severe intrauterine growth retardation (IUGR).  No other information was provided.  Additional information has been requested.
Throbbing in my head as if to start a headache, shortness of breath, pressure in the chest, dizziness, fluttering of the heart, feeling agitated.
Information has been received from a physician concerning an 8 month old patient who in approximately October 2006, six months ago, was vaccinated with rotavirus vaccine (human-bovine) for the first dose. The physician reported that the patient experienced vomiting and diarrhea after receiving rotavirus vaccine (human-bovine). Therapy with rotavirus vaccine (human-bovine) was discontinued. Subsequently, the patient recovered from vomiting and diarrhea. The physician reported that the patient will not finish the series. Additional information has been requested.
got shingles; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of shingles in an unspecified number of patients who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, several days after receiving Shingles vaccine, the patient experienced shingles (Verbatim: got shingles). The outcome of the shingles was not reported.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.   It was unknown if the company considered the shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 18-MAR-2023 This case was reported by a consumer via interactive digital media. The reporter stated that why it was that a couple people he/she knew got shingles right after they got shingles jabbed. The follow up would not possible as no contact details were available.
Persistent headache; 100 degree fever; This is a spontaneous report from a contactable other healthcare professional, the patient. A 41-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 05Apr2021 at 12:30 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Concomitant medications included atorvastatin calcium (LIPITOR) 10 mg from an unknown date for an unspecified indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 16Mar2021 at 15:30 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 10:00, the patient experienced persistent headache and 100-degree fever. The patient did not receive any treatment for the events. The adverse events did not result in doctor or other healthcare professional office/clinic visit/ emergency visit. The clinical outcome of the events persistent headache and fever was recovering at the time of reporting.   No follow-up attempts are needed. No further information is expected.
first shot = very sore arm without redness, moderate headache, mild fatigue no other symptoms second shot friday at 3pm,  that night I developed a severe headache, muscle aches, joint aches, too painful to sleep, started dry heaving at 6am saturday morning, major fatigue, slept from 7am until 5 pm saturday, woke nauseated, still muscle and joint aches, fever 100 degrees F on ibuprofen and nyquil, went back to sleep at 9pm saturday, woke 7am sunday, felt much better - no more joint aches, muscle aches greatly diminished, nausea gone, but major headache/throbbing still there, and began experiencing vertigo as soon as I woke. I have only experienced vertigo once before (years ago). Vertigo impacted ability to walk and function normally. Did not cause nausea though. Vertigo lessened over the day, nearly gone by late afternoon Sunday. Headache still present, continued to take ibuprofen/nyquil, woke Monday morning with severe headache and some confusion, only very slight vertigo. Confusion is new. Trying to work from home, having difficulty with comprehension. Just had to listen to a voicemail five times to understand information provided. This is very atypical for me. I feel kind of strange, checked my smartwatch, and my resting heartate went up the day I was vaccinated to higher than it's been since I had a smartwatch (several years ago), still up/increasing, so al though I didn't realize it, I was also experiencing increasing heartrate. It is still increasing. I have gone from  68 on Friday to 70 on Saturday to 72 on Sunday to 74 bpm today.  I've never been this high. The increased heart rate, confusion, and dizziness is why I'm deciding to report - headache I am sure happens to everyone.
chronic  joint stiffness in the neck, back and hip bone for past two months occurring after the second dose.   Attending Physical Therapy to relieve spinal stiffness in neck.
Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M2DA) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On the night of 30-Jan-2021, the patient experienced diarrhoea (watery stools) twice. Concomitant medications were not provided. Treatment information was not reported.
Patient was 5 years old when patient received Covid Vaccine for 6 months- 4 years old.
Patient began to feel lightheaded.  Was sitting upright and feeling warm.  Cool washcloth was placed on the patients forehead and he was instructed to lay down.  Patient's vital signs were monitored every 5 minutes.  Skin was moist to the touch on the forehead.  Patient does have a history of fainting with IM injections and lab draws.  Patient drank water  and orange juice.  Plan was discussed for the second vaccine and the patient left under the care of his sister at 1225pm.
only the adjuvant was given to a patient / only the adjuvant was drawn up in the syringe; only the adjuvant was given to a patient / only the adjuvant was drawn up in the syringe; This case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a 54-year-old female patient who received Herpes zoster (Shingrix) (batch number Z22C5, expiry date 6th November 2022) for prophylaxis.   On 27th May 2021, the patient received Shingrix. On 27th May 2021, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The pharmacist reported that, only the adjuvant was administered to the patient due to emergency situation, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The health care professional was not aware that only the adjuvant was drawn up in the syringe. The reporter did not consented to follow up.
MMR given 8/25/09. Taken to ER on 9/2/09 with high fever (103.5) and febrile seizure. Child had convulsions, stopped breathing and turned blue.
Pt recieved Tdap and Menveo vaccines during visit with Immunizations Clinic. Upon exiting the clininc Pt attempted to close the office door behind him and stumbled. Pt turned to face door and attempted to pull it closed again. He began to collapse while hanging onto the door handle, at which time staff supported Pt from falling to floor and moved him to exam table within treatment room. Staff memeber notified supervisor near by who alerted nursing staff and provider. Staff memeber stayed with Pt while awaiting provider arrival and monitored for further progression of altered behavior and for signs of allergic reaction. Pt very upset, weak, pale, and faint. Provider and nurse assessed Pt; released to care of parent.
No patients experienced symptoms; unspecified patients may have been administered improperly stored doses of PEDVAX HIB, GARDASIL 9, RECOMBIVAX HB and ROTATEQ; This spontaneous report was received from a nurse and refers to an unspecified number of patients of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent conditions, concomitant and historical drugs was not provided.  On unknown dates, the patients were vaccinated with improperly stored doses of the following vaccines: Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB) lot # R036178 with expiration date on 09-OCT-2021, and lot # R027329 with expiration date on 12-JUL-2021; HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) lot # S026372 and expiration date on 01-APR-2022, and lot # R029507 with expiration date on 10-JUL-2021; Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB) lot # R031056 with expiration date on 04-JUN-2021, and lot # R031055 with expiration date on 04-JUN-2021; and Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) orally, lot # 1660685 with expiration date on 21-MAR-2021, and lot # S005875 with expiration date on 30-NOV-2020, (strength, dosing details were not reported) via unknown route, all vaccines for prophylaxis.  It was reported that the vaccines were exposed to a temperature of 47.6-degree Fahrenheit for 41 minutes and 31.9-degree Fahrenheit for 6 hours and 58 minutes. There was not previous temperature excursion. It was reported that digital data logger was involved. No symptoms were reported.  This is a non-valid case due to the lack of patient's identifiers.  Follow-up information was received on 03-MAR-2020 from a nurse supervisor.  The nurse referred to an 8-months-old female patient (previously considered non-valid).  On 17-JAN-2020, the patient was vaccinated with improperly stored Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB) (strength not reported) lot # R031056 with expiration date on 04-JUN-2021 for prophylaxis (product storage error).  The reporter confirmed that there had been no reports of adverse event following the administration of the vaccinations. She also reported that no patients received the Merck vaccination Hemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB). Additional information has been requested.  This is one of the several reports by the same reporter.; Sender's Comments:  US-009507513-2003USA001375: US-009507513-2001USA006732: US-009507513-2003USA001379: US-009507513-2003USA001376: US-009507513-2003USA001378: US-009507513-2003USA001377:
received Moderna vaccines on 1/28/21, 2/25/21 Tested positive for COVID by PCR on 8/24/21. Admitted to hospital on 8/24/21, asymptomatic from COVID thus far but hospitalized due to osteomyelitis